Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133360) titled 'Clinical study of presynaptic dopaminergic 18F-DOPA radionuclide molecular probe' on Sept. 24.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: The First Affiliated Hospital of Guilin Medical University
Condition:
Parkinson's disease
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-10-01
Target Sample Size: 18F-DOPA imaging group:20;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=345022
Published by HT Digital Content Services with permission from Health Daily Digest....